Infinity Pharmaceuticals Inc. (NASDAQ:INFI) went up by 15.87% from its latest closing price compared to the recent 1-year high of $3.89. The company’s stock price has collected 14.30% of gains in the last five trading sessions.
Is It Worth Investing in Infinity Pharmaceuticals Inc. (NASDAQ :INFI) Right Now?
Plus, the 36-month beta value for INFI is at 1.96. Opinions of the stock are interesting as 7 analysts out of 7 who provided ratings for Infinity Pharmaceuticals Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $6.07, which is $5.24 above the current price. INFI currently public float of 88.12M and currently shorts hold a 5.38% ratio of that float. Today, the average trading volume of INFI was 756.67K shares.
INFI’s Market Performance
INFI stocks went up by 14.30% for the week, with a monthly jump of 34.51% and a quarterly performance of -16.62%, while its annual performance rate touched -73.19%. The volatility ratio for the week stands at 14.13% while the volatility levels for the past 30 days are set at 14.81% for Infinity Pharmaceuticals Inc. The simple moving average for the period of the last 20 days is 17.90% for INFI stocks with a simple moving average of -51.19% for the last 200 days.
Analysts’ Opinion of INFI
Many brokerage firms have already submitted their reports for INFI stocks, with H.C. Wainwright repeating the rating for INFI by listing it as a “Buy.” The predicted price for INFI in the upcoming period, according to H.C. Wainwright is $9 based on the research report published on October 18th of the previous year 2021.
JP Morgan, on the other hand, stated in their research note that they expect to see INFI reach a price target of $6. The rating they have provided for INFI stocks is “Overweight” according to the report published on August 02nd, 2021.
Wells Fargo gave a rating of “Overweight” to INFI, setting the target price at $14 in the report published on July 28th of the previous year.
INFI Trading at 13.54% from the 50-Day Moving Average
After a stumble in the market that brought INFI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.57% of loss for the given period.
Volatility was left at 14.81%, however, over the last 30 days, the volatility rate increased by 14.13%, as shares surge +46.08% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.76% lower at present.
During the last 5 trading sessions, INFI rose by +14.30%, which changed the moving average for the period of 200-days by -77.77% in comparison to the 20-day moving average, which settled at $0.7204. In addition, Infinity Pharmaceuticals Inc. saw -62.94% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for INFI
Current profitability levels for the company are sitting at:
- -2426.43 for the present operating margin
- +13.89 for the gross margin
The net margin for Infinity Pharmaceuticals Inc. stands at -2436.06. Equity return is now at value -175.10, with -52.00 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 6.19.